Excipients used in pharmaceutical formulation and development are important. These substances contain ingredients besides the drug or prodrug that is pharmacologically active. Drug delivery to the target site is facilitated by pharmaceutical excipients. These molecules assimilate and improve the drug's effectiveness while preventing the drug from being released too early. Some excipients used in pharmaceuticals encourage drug integration, which increases drug absorption in the bloodstream. Pharmaceutical excipients are additionally used to identify drugs.
Access Full Report @ https://www.databridgemarketresearch.com/es/reports/global-pharmaceutical-excipients-market
Data Bridge Market Research analyses that the Pharmaceutical Excipients Market is expected to reach the value of USD 12,199.90 million by 2029, at a CAGR of 6.6% during the forecast period. The expanding pharmaceutical industry, driven by increasing global population, aging demographics, and rising healthcare needs, fuels the demand for pharmaceutical excipients as essential components in drug formulation.
Increase in generic drugs is expected to drive the market's growth rate
The increase in generic drug production, resulting from patent expirations and cost-saving initiatives, has led to a significant demand for pharmaceutical excipients. Generic drug manufacturers rely on excipients to develop cost-effective and safe formulations that are bioequivalent to their branded counterparts. Excipients play a crucial role in ensuring the stability, functionality, and overall quality of generic drugs, making them an essential component in the formulation process for these manufacturers.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Functionality (Binders And Adhesives, Disintegrants, Coating Material, Coloring Agents, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants,Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidents, Chelating Agents, Antifoaming Agents, and Others), Dosage Form (Solid, Semi-Solid, Liquid), Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, Other Excipients), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, Others), Distribution Channel (Direct Tender, Retail Sales, Others).
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Kerry Group plc. (Ireland), DFE Pharma (Netherlands), Cargill, Incorporated (U.S.), Pfanstiehl (U.S.), Colorcon (U.S.), MEGGLE GmbH & Co. KG (Germany), Omya AG (Switzerland), Peter Greven GmbH & Co. KG (Germany), Ashland (U.S.), Evonik (Germany), Dow (U.S.), Croda International Plc (U.K.), Roquette Frères (France), The Lubrizol Corporation (U.S.), BASF SE (Germany), Avantor, Inc. (U.S.), BENEO (Germany), Chemie Trade (Germany) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The pharmaceutical excipients market is segmented on the basis of functionality, dosage forms, route of administration, end user, and distribution channel.
- On the basis of functionality, the global pharmaceutical excipients market is segmented into binders and adhesives, disintegrants, coating material, coloring agents, solubilizers, flavors, sweetening agents, diluents, lubricants, buffers, emulsifying agents, preservatives, antioxidants, sorbents, solvents, emollients, glidents, chelating agents, antifoaming agents, and others. In 2022, the binders and adhesives segment is expected to dominate the global pharmaceutical excipients market with a CAGR of 9.8% in the forecast period of 2022 to 2029 due to low active dose tablets. Commonly used in wet granulation, binders are added to create a more effective and predictable granule formulation.
In 2021, the binders and adhesives segment is expected to dominate the functionality of the global pharmaceutical excipients market.
In 2021, the binders and adhesives segment is expected to dominate the global pharmaceutical excipients market owing to essential for tablet formulations to hold the ingredients together. Coating materials are used to provide a protective layer and improve the appearance of tablets. Disintegrants aid in the breakdown of tablets or capsules for faster drug release. Diluents are used as fillers to increase the bulk of tablets or capsules with a CAGR of 9.8% in the forecast period of 2022 to 2029.
- On the basis of dosage form, the global pharmaceutical excipients market is segmented into solid, semi-solid, and liquid. Solid segment is expected to dominate the global pharmaceutical excipients market with a CAGR of 6.8% in the forecast period of 2022 to 2029 due to most pharmaceutical excipients are used to manufacture solid dosage forms. Active pharmaceutical ingredient (API) is used to manufacture solid dosage forms in low quantities. So, pharmaceutical excipients are used to improve stability and increase the volume of the dosage form.
- On the basis of route of administration, the global pharmaceutical excipients market is segmented into oral excipients, topical excipients, parenteral excipients, and other excipients. Oral excipients segment is expected to dominate the global pharmaceutical excipients market with a CAGR of 7.1% in the forecast period of 2022 to 2029 due to therapy, are available in the oral form with the highest effectiveness, enhanced bioavailability, and strong onset of action.
- On the basis of end user, the global pharmaceutical excipients market is segmented into pharmaceutical and biopharmaceutical companies, contract formulators, research organizations and academics, and others. The pharmaceutical and biopharmaceutical companies segment is expected to dominate the global pharmaceutical excipients market with a CAGR of 7.0% in the forecast period of 2022 to 2029 due to market since most pharmaceutical excipients used in these companies are responsible for producing medicines in all dosage forms, such as solid, semi-solid, and liquid. Pharmaceutical excipients are used in the manufacturing of these dosage forms of medicines.
In 2022, the pharmaceutical and biopharmaceutical companies segment is expected to dominate the end user segment of the global pharmaceutical excipients market
In 2022, the pharmaceutical and biopharmaceutical companies segment is expected to dominate the global pharmaceutical excipients market owing to companies rely on advanced research and innovative technologies to discover and manufacture drugs for the treatment of various conditions, including interstitial cystitis (IC) with a CAGR of 7.0% in the forecast period of 2022 to 2029.
- On the basis of distribution channels, the global pharmaceutical excipients market is segmented into direct tender, retail sales, and others. In 2022, the direct tender segment is expected to dominate the global pharmaceutical excipients market with a CAGR of 7.0% in the forecast period of 2022 to 2029 due to the primary distribution source of pharmaceutical excipients. Hence, the market players deal directly with pharmaceutical excipients for further manufacturing.
Major Players
Data Bridge Market Research recognizes the following companies as the major pharmaceutical excipients market players in pharmaceutical excipients market are Kerry Group plc. (Ireland), DFE Pharma (Netherlands), Cargill, Incorporated (U.S.), Pfanstiehl (U.S.), Colorcon (U.S.), MEGGLE GmbH & Co. KG (Germany), Omya AG (Switzerland), Peter Greven GmbH & Co. KG (Germany), Ashland (U.S.), Evonik (Germany)
Market Development
- In 2022, The biggest taste and nutrition company in the world, Kerry Group Plc., revealed that it had expanded its knowledge, technology portfolio, and manufacturing capabilities through the acquisition of two significant biotechnology companies.
- In 2022, A long-standing problem in drug development, poor bioavailability has been addressed by CD Formulation through the launch of tailored solutions for increased bioavailability excipients.
- In 2022, In Hyderabad, India, DFE Pharma, a leader in excipient solutions for pharma- and nutraceuticals, launched its newest "Closer to the Formulator" (C2F) Center of Excellence.
- In 2021, A new product line called BioHale was launched by DFE Pharma, a supplier of pharmaceutical excipient solutions, to assist biopharmaceutical companies in resolving supply issues on a global scale.
- In 2021, Croda International Plc went under a partnership with Genesis Biosciences with an aim to develop high-performing technologies and ingredients.
- In 2021, Roquette introduced LYCAGEL Premix, a ready-to-use pharmaceutical-grade solution for the formulation of vegetarian soft gel capsules.
Regional Analysis
Geographically, the countries covered in the pharmaceutical excipients market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in pharmaceutical excipients market during the forecast period 2022-2029
North America is a dominant force in the global pharmaceutical excipients market, driven by increasing investments in research and development. The U.S. plays a significant role within the region, primarily due to the strong presence of key players such as Evonik, Dow, Croda International Plc, and others. These companies contribute to the market's growth by continuously innovating and developing high-quality excipients, thereby meeting the rising demand for advanced formulation solutions in the pharmaceutical industry.
Asia-Pacific is estimated to be the fastest growing region in pharmaceutical excipients market the forecast period 2022-2029
China holds a dominant position in the Asia-Pacific region's pharmaceutical excipients market. This is attributed to the rapid growth of the pharmaceutical industry in China and the increasing production of generic drugs. The country's large population, expanding healthcare needs, and government initiatives to promote affordable healthcare have fueled the demand for pharmaceutical excipients. Chinese manufacturers are focusing on producing cost-effective excipients to meet the rising demand for generic drugs, contributing to China's dominance in the region's pharmaceutical excipients market.
For more detailed information about the pharmaceutical excipients market report, click here – https://www.databridgemarketresearch.com/es/reports/global-pharmaceutical-excipients-market
